These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4085560)

  • 21. tGS ganglioside induces peculiar morphological features in grafted dopaminergic cells and promotes motor recovery in rats with unilateral lesions in the nigrostriatal dopamine pathway.
    Nishino H; Hashitani T; Isobe Y; Furuyama F; Sato H; Kumazaki M; Horikomi K; Awaya A
    Brain Res; 1990 Nov; 534(1-2):73-82. PubMed ID: 1981486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfatide and GM1 ganglioside modulate the high-affinity dopamine uptake in rat striatal synaptosomes: evidence for the involvement of their ionic charges.
    Barrier L; Page G; Barc S; Piriou A; Portoukalian J
    Neurochem Int; 2003 Mar; 42(4):305-13. PubMed ID: 12470704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system.
    Toffano G; Savoini G; Moroni F; Lombardi G; Calza L; Agnati LF
    Brain Res; 1983 Feb; 261(1):163-6. PubMed ID: 6132660
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment with GM1 ganglioside reverses dopamine D-2 receptor supersensitivity induced by the neurotoxin MPTP.
    Hadjiconstantinou M; Weihmuller F; Neff NH
    Eur J Pharmacol; 1989 Sep; 168(2):261-4. PubMed ID: 2532603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
    Javoy F; Sotelo C; Herbet A; Agid Y
    Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP.
    Hadjiconstantinou M; Rossetti ZL; Paxton RC; Neff NH
    Neuropharmacology; 1986 Sep; 25(9):1075-7. PubMed ID: 3490632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat.
    Borawska M; Wiśniewski K
    Pol J Pharmacol Pharm; 1982; 34(1-3):79-84. PubMed ID: 7167424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective enhancement of tubulin gene expression and increase in oligo(dT)-bound RNA in the rat brain after nigrostriatal pathway unilateral lesion and treatment with ganglioside.
    Yavin E; Gil S; Consolazione A; dal Toso R; Leon A
    J Neurosci Res; 1987; 18(4):615-20. PubMed ID: 3437475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride.
    Filloux FM; Wamsley JK; Dawson TM
    Eur J Pharmacol; 1987 Jun; 138(1):61-8. PubMed ID: 3113982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat.
    Agnati LF; Benfenati F; Battistini N; Cavicchioli L; Fuxe K; Toffano G
    Acta Physiol Scand; 1983 Feb; 117(2):311-4. PubMed ID: 6869038
    [No Abstract]   [Full Text] [Related]  

  • 35. Synaptosomal uptake and release of dopamine in substantia nigra: effects of gamma-aminobutyric acid and substance P.
    Silbergeld EK; Walters JR
    Neurosci Lett; 1979 Apr; 12(1):119-26. PubMed ID: 460694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phorbol esters potentiate rapid dopamine release from median eminence and striatal synaptosomes.
    Shu C; Selmanoff M
    Endocrinology; 1988 Jun; 122(6):2699-709. PubMed ID: 3131121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of naloxone on dopamine uptake and release in vitro in the striatum.
    Feigenbaum JJ; Yanai J; Iser C; Klawans H
    Neuropsychobiology; 1984; 11(2):94-7. PubMed ID: 6483167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.